Zicix (OTCMKTS:ZICXD – Get Free Report) and Danaher (NYSE:DHR – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.
79.1% of Danaher shares are held by institutional investors. 10.8% of Danaher shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
This table compares Zicix and Danaher’s net margins, return on equity and return on assets.
This table compares Zicix and Danaher”s top-line revenue, earnings per share (EPS) and valuation.
Danaher has higher revenue and earnings than Zicix. Zicix is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.
Zicix has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500. Comparatively, Danaher has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.
This is a breakdown of current ratings and price targets for Zicix and Danaher, as reported by MarketBeat.
Danaher has a consensus price target of $233.61, suggesting a potential upside of 29.82%. Given Danaher’s stronger consensus rating and higher possible upside, analysts plainly believe Danaher is more favorable than Zicix.
Danaher beats Zicix on 13 of the 13 factors compared between the two stocks.
Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.